Effects of physical exercise on anxiety depression and emotion regulation in children with attention deficit hyperactivity disorder: a systematic review and meta-analysis.

Yagang Song, Shuqi Jia, Xing Wang, Aiwei Wang, Tao Ma, Shufan Li, Jiwei Chen, Zhaohui Guo, Feng Ding, Yuxi Ren, Man Qin
Author Information
  1. Yagang Song: Department of Physical Education Teaching, Shanghai Sanda University, Shanghai, China.
  2. Shuqi Jia: Physical Education, Shanghai University of Sport, Shanghai, China.
  3. Xing Wang: Physical Education, Shanghai University of Sport, Shanghai, China.
  4. Aiwei Wang: Physical Education, Yangzhou University, Yangzhou, China.
  5. Tao Ma: Faculty of Sports Science, Ningbo University, Ningbo, China.
  6. Shufan Li: Physical Education, Shanghai University of Sport, Shanghai, China.
  7. Jiwei Chen: Physical Education, Shanghai University of Sport, Shanghai, China.
  8. Zhaohui Guo: Physical Education, Shanghai University of Sport, Shanghai, China.
  9. Feng Ding: Physical Education, Shanghai University of Sport, Shanghai, China.
  10. Yuxi Ren: Physical Education, Shanghai University of Sport, Shanghai, China.
  11. Man Qin: School of Sports and Health, Shanghai Lixin Accounting and Finance University, Shanghai, China.

Abstract

Objective: This systematic review and meta-analysis aimed to comprehensively evaluate the impact of physical exercise interventions on anxiety, depression, and emotional regulation in children diagnosed with attention deficit hyperactivity disorder (ADHD).
Methods: A comprehensive search was conducted across multiple databases, including Embase, Web of Science (WOS), PubMed, The Cochrane Library, Wanfang Data, VIP Information, and China National Knowledge Infrastructure (CNKI), from their inception up to July 2024. The search aimed to identify randomized controlled trials (RCTs) investigating the impact of physical exercise on anxiety, depression, and emotional regulation in children diagnosed with ADHD. The Physiotherapy Evidence Database (PEDro) scale was employed to assess the quality of the literature, while the revised Cochrane risk-of-bias tool (ROB-2) was used to evaluate the overall risk of bias. The Grading of Recommendations, Assessment, Development and Evaluation (GRADE) profiler method was utilized to further assess the quality of evidence. Meta-analysis, sensitivity analysis, and publication bias testing were performed using Stata 18.0 software. Effect sizes were calculated using the standardized mean difference (SMD) and 95% confidence intervals (CI).
Results: The analysis included 18 RCTs, encompassing 830 participants. Physical exercise exhibited a significant positive effect on anxiety (SMD���=���-0.58, ���<���0.05), depression (SMD���=���-0.57, ���<���0.05), and emotional regulation (SMD���=���1.03, ���<���0.05) in children diagnosed with ADHD. Subgroup analysis revealed that exercise programs with monotypic and mixed modalities, short duration, high frequencies, medium duration, and moderate intensities were the most efficacious in ameliorating anxiety symptoms. The mixed exercise program, when conducted for short duration, with low frequencies, medium duration, and moderate intensity was the most effective in alleviating depression symptoms. Exercise programs featuring mixed modalities, longer duration, moderate to high frequencies, shorter duration, and low intensity yielded the most significant improvements in emotional regulation.
Conclusions: Research demonstrates that physical exercise mitigates anxiety and depression and improves emotional regulation in children with ADHD. A dose-response relationship is evident, correlating with the type, duration, intensity, frequency, and overall exercise duration.
Systematic Review Registration: https://www.crd.york.ac.uk/prospero/, PROSPERO identifier (CRD42024571577).

Keywords

References

  1. Front Psychol. 2021 Jun 14;12:660845 [PMID: 34194365]
  2. Am J Psychiatry. 2022 Feb;179(2):142-151 [PMID: 34384227]
  3. J Atten Disord. 2022 Mar;26(5):656-673 [PMID: 34041952]
  4. J Am Acad Child Adolesc Psychiatry. 2013 Sep;52(9):900-10 [PMID: 23972692]
  5. J Atten Disord. 2017 Sep;21(11):898-903 [PMID: 25359761]
  6. Lancet Child Adolesc Health. 2022 Dec;6(12):845-856 [PMID: 36306807]
  7. BMJ. 2021 Mar 29;372:n160 [PMID: 33781993]
  8. Age Ageing. 2021 Jun 28;50(4):1084-1092 [PMID: 33338209]
  9. Scand J Med Sci Sports. 2015 Jun;25(3):e331-8 [PMID: 25134779]
  10. J Altern Complement Med. 2018 May;24(5):463-471 [PMID: 29641212]
  11. Borderline Personal Disord Emot Dysregul. 2023 Sep 25;10(1):28 [PMID: 37743484]
  12. J Affect Disord. 2021 Feb 15;281:708-713 [PMID: 33234281]
  13. J Abnorm Child Psychol. 2015 May;43(4):655-67 [PMID: 25201345]
  14. Int J Environ Res Public Health. 2022 Dec 04;19(23): [PMID: 36498313]
  15. Int J Environ Health Res. 2020 Oct;30(5):584-592 [PMID: 31081373]
  16. Pediatrics. 2023 Jan 1;151(1): [PMID: 36510746]
  17. J Autism Dev Disord. 2022 Mar;52(3):1030-1050 [PMID: 33856619]
  18. J Clin Psychopharmacol. 2021 May-Jun 01;41(3):310-314 [PMID: 33657069]
  19. Neurosci Biobehav Rev. 2024 Aug;163:105774 [PMID: 38914177]
  20. Psychiatry Res. 2022 May;311:114509 [PMID: 35305344]
  21. J Atten Disord. 2009 May;12(6):499-506 [PMID: 18596300]
  22. Clin Psychol Rev. 2021 Feb;83:101954 [PMID: 33418192]
  23. BMJ. 2008 Apr 26;336(7650):924-6 [PMID: 18436948]
  24. Int J Dev Neurosci. 2022 Jun;82(4):295-302 [PMID: 35274372]
  25. Neurosci Biobehav Rev. 2021 Sep;128:735-748 [PMID: 34256070]
  26. Curr Psychiatry Rep. 2019 Mar 2;21(3):17 [PMID: 30826879]
  27. J Atten Disord. 2004 May;7(4):205-16 [PMID: 15487477]
  28. JMIR Form Res. 2024 Jan 17;8:e53931 [PMID: 38231536]
  29. Eur Child Adolesc Psychiatry. 2024 May;33(5):1419-1432 [PMID: 37368082]
  30. Int J Sports Physiol Perform. 2021 Feb 27;16(4):605-608 [PMID: 33639611]
  31. Hum Brain Mapp. 2022 Jan;43(1):37-55 [PMID: 32420680]
  32. Front Psychiatry. 2024 Apr 16;15:1329401 [PMID: 38690203]
  33. Front Sports Act Living. 2022 Feb 24;4:746409 [PMID: 35280225]
  34. J Atten Disord. 2021 Jun;25(8):1187-1195 [PMID: 31838947]
  35. Epidemiol Bull. 1997 Mar;18(1):1-4 [PMID: 9197082]
  36. Res Dev Disabil. 2021 Nov;118:104063 [PMID: 34507050]
  37. Psychiatry Res. 2022 Apr;310:114423 [PMID: 35152068]
  38. Disabil Health J. 2023 Jan;16(1):101377 [PMID: 36202733]
  39. Res Dev Disabil. 2016 Oct;57:1-10 [PMID: 27344348]
  40. Am J Psychiatry. 1991 May;148(5):564-77 [PMID: 2018156]
  41. Lancet Psychiatry. 2018 Sep;5(9):727-738 [PMID: 30097390]
  42. J Atten Disord. 2024 Feb;28(4):399-414 [PMID: 38156611]
  43. Res Dev Disabil. 2016 Dec;59:176-185 [PMID: 27614276]
  44. BMJ. 2009 Jul 21;339:b2535 [PMID: 19622551]
  45. J Physiother. 2020 Jan;66(1):59 [PMID: 31521549]
  46. PLoS One. 2023 Jan 6;18(1):e0280131 [PMID: 36608036]
  47. Res Child Adolesc Psychopathol. 2024 Apr;52(4):605-620 [PMID: 37843650]
  48. J Child Adolesc Psychopharmacol. 2018 Oct;28(8):494-507 [PMID: 29897263]
  49. Front Psychiatry. 2019 Mar 26;10:132 [PMID: 30971959]
  50. J Nerv Ment Dis. 2013 Sep;201(9):727-9 [PMID: 23995026]
  51. J Atten Disord. 2018 Jun;22(8):806-812 [PMID: 27013028]
  52. Brain Sci. 2020 May 14;10(5): [PMID: 32422912]
  53. Pharmacol Ther. 2022 Feb;230:107940 [PMID: 34174276]
  54. J Neurosci. 2022 Jun 8;42(23):4725-4736 [PMID: 35577554]
  55. J Child Psychol Psychiatry. 2022 Dec;63(12):1583-1590 [PMID: 35484998]
  56. Front Pediatr. 2023 Jun 30;11:1193648 [PMID: 37456563]
  57. Front Sports Act Living. 2023 May 15;5:1133256 [PMID: 37255729]
  58. Evid Based Ment Health. 2016 Feb;19(1):16-21 [PMID: 26792834]
  59. J Affect Disord. 2024 Aug 15;359:189-195 [PMID: 38768826]
  60. Eur Neuropsychopharmacol. 2022 Apr;57:69-74 [PMID: 35151951]
  61. Front Psychiatry. 2021 Oct 26;12:706625 [PMID: 34764893]
  62. Nat Hum Behav. 2020 Jun;4(6):603-612 [PMID: 32231280]
  63. Med Sci Sports Exerc. 2015 Jan;47(1):33-9 [PMID: 24824770]

Word Cloud

Created with Highcharts 10.0.0exercisedurationanxietydepressionregulationemotionalphysicalchildrenADHDmeta-analysisdiagnosedattentiondeficithyperactivityanalysis���<���005mixedfrequenciesmoderateintensitysystematicreviewaimedevaluateimpactdisordersearchconductedCochraneRCTsassessqualityoverallbiasusing18significantSMD���=���-0programsmodalitiesshorthighmediumsymptomslowObjective:comprehensivelyinterventionsMethods:comprehensiveacrossmultipledatabasesincludingEmbaseWebScienceWOSPubMedLibraryWanfangDataVIPInformationChinaNationalKnowledgeInfrastructureCNKIinceptionJuly2024identifyrandomizedcontrolledtrialsinvestigatingPhysiotherapyEvidenceDatabasePEDroscaleemployedliteraturerevisedrisk-of-biastoolROB-2usedriskGradingRecommendationsAssessmentDevelopmentEvaluationGRADEprofilermethodutilizedevidenceMeta-analysissensitivitypublicationtestingperformedStata0softwareEffectsizescalculatedstandardizedmeandifferenceSMD95%confidenceintervalsCIResults:includedencompassing830participantsPhysicalexhibitedpositiveeffect5857SMD���=���103SubgrouprevealedmonotypicintensitiesefficaciousamelioratingprogrameffectivealleviatingExercisefeaturinglongershorteryieldedimprovementsConclusions:Researchdemonstratesmitigatesimprovesdose-responserelationshipevidentcorrelatingtypefrequencySystematicReviewRegistration:https://wwwcrdyorkacuk/prospero/PROSPEROidentifierCRD42024571577Effectsemotiondisorder:

Similar Articles

Cited By